Cargando…
Pre-clinical models for evaluating glioma targeted immunotherapies
Gliomas have an extremely poor prognosis in both adult and pediatric patient populations as these tumors are known to grow aggressively and respond poorly to standard of care treatment. Currently, treatment for gliomas involves surgical resection followed by chemoradiation therapy. However, some gli...
Autores principales: | Frederico, Stephen C., Zhang, Xiaoran, Hu, Baoli, Kohanbash, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870312/ https://www.ncbi.nlm.nih.gov/pubmed/36700223 http://dx.doi.org/10.3389/fimmu.2022.1092399 |
Ejemplares similares
-
Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier
por: Frederico, Stephen C., et al.
Publicado: (2023) -
Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models
por: Chen, Apeng, et al.
Publicado: (2023) -
DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
por: Chen, Mu, et al.
Publicado: (2022) -
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
por: Zeng, Jiayi, et al.
Publicado: (2021) -
Immunotherapy: a promising approach for glioma treatment
por: Yasinjan, Feroza, et al.
Publicado: (2023)